Netosis in Trauma mediated Acute Lung Injury
创伤介导的急性肺损伤中的网沉着
基本信息
- 批准号:10371817
- 负责人:
- 金额:$ 18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-14 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:Activation AnalysisAcute Lung InjuryAddressAdoptive TransferAnti-Infective AgentsAntibodiesBacteriaBacterial PneumoniaBiologicalBiological AssayBronchoalveolar LavageCD28 geneCD3 AntigensCSF3 geneChemicalsComplicationCytoplasmic GranulesDNADataDevelopmentEnzyme-Linked Immunosorbent AssayEnzymesFDA approvedFlow CytometryGenerationsGeneticGoalsHistone H3HospitalizationHost DefenseImmobilizationImmune System DiseasesImmune responseImmunologicsImmunophenotypingIncubatedInfectionInflammationInflammatory ResponseInjuryInnate Immune SystemInpatientsInterferon Type IIInternetInvadedK-Series Research Career ProgramsKnowledgeLaboratoriesLeukocytesLymphocyteLymphocyte FunctionMeasuresMediatingMultiple TraumaMusNosocomial pneumoniaPathway interactionsPatient-Focused OutcomesPatientsPharmacologyPhysiciansPlasmaPneumoniaPredispositionPreventionProductionProtocols documentationPseudomonasPseudomonas aeruginosaPseudomonas aeruginosa pneumoniaResearchRespiratory Tract InfectionsRiskRoleScientistSecondary toSepsisSerumSignal TransductionSplenocyteStainsSterilityTNF geneTechnologyTestingTherapeuticTissuesTrainingTranslatingTraumaTrauma patientTraumatic injuryUp-Regulationantimicrobialbaseclinically translatablecytokinecytotoxicdefined contributionexperimental studyextracellularimmunocytochemistryimprovedimproved outcomeinhibitor/antagonistinjuredinsightintravital microscopyleukocyte activationlung injurymonocytemouse modelneutrophilnovelpathogenperipheral bloodpost-traumapreventresponsesecondary infectionsevere injuryskillssystemic inflammatory responsetherapy developmenttime intervaltissue injurytool
项目摘要
PROJECT SUMMARY
Up to 40% of critically injured trauma patients will develop a serious infectious complication during their inpatient
hospitalization and respiratory infections are the most common cause of sepsis in injured patients. While it is known
that traumatic injury triggers a sterile inflammatory response that can result in acute lung injury (ALI), the mechanism of
this and its contribution to the development of secondary infections such as pneumonia is not well understood. The
overarching goal of this research is to understand the role of the innate immune system in trauma induced lung injury in
order to provide new targets for treatment and prevention. We have recently established a mouse model of polytrauma
that recapitulates the increased susceptibility to gram negative pneumonia seen in critically injured patients. In
preliminary studies, we demonstrate that trauma alone induces both an acute lung injury and increased susceptibility to
Pseduomonas pneumonia. We further find an increase in neutrophil NETosis following a second insult with
pseudomonas bacteria. Neutrophil NETosis is a strong antimicrobial neutrophil response whereby activated neutrophils
extrude a web of DNA studded with cytotoxic granules which function to immobilize and kill invading pathogens. While
NETosis is a critical anti-infective pathway, excessive NETosis has been demonstrated to result in collateral damage to
host tissues. We also show that serum from traumatically injured mice can prime unactivated neutrophils for NETosis.
Based on these data we hypothesize that trauma primes neutrophils for NETosis causing ALI and an overexuberant
response to gram negative bacterial pneumonia after trauma. To test this hypothesis we propose two specific aims.
Aim 1: Determine if neutrophil NETosis triggered by polytrauma-induced ALI exacerbates pneumonia.
Aim 2: Define the the role of GCSF in promoting NETosis after polytrauma
AIM3: Define the contribution of neutrophil NETosis to the dysregulated immune response induced by a secondary
infection after trauma.
The knowledge gained from successfully achieving these aims will provide a novel pathway to prevent and treat ALI after
trauma and are clinically translatable as several current FDA approved therapeutics are known to have activity against
key enzymes required for NETosis and multiple specific therapeutics are currently being developed. This knowledge is
crucial so that Dr. Leonard’s laboratory can translate these to development of mechanistic therapies that may improve
patient outcomes.
项目概要
多达 40% 的重伤创伤患者在住院期间会出现严重的感染性并发症
众所周知,住院和呼吸道感染是导致受伤患者败血症的最常见原因。
创伤性损伤会引发无菌炎症反应,从而导致急性肺损伤(ALI),其机制
这一现象及其对肺炎等继发感染的影响尚不清楚。
这项研究的首要目标是了解先天免疫系统在创伤引起的肺损伤中的作用
为了为治疗和预防提供新的靶点,我们最近建立了多发性创伤的小鼠模型。
这概括了重伤患者对革兰氏阴性肺炎的易感性增加。
初步研究表明,仅创伤就会引起急性肺损伤并增加对肺损伤的易感性
我们进一步发现第二次损伤后中性粒细胞网病增加。
假单胞菌 NETosis 是一种强烈的中性粒细胞抗菌反应,从而激活中性粒细胞。
挤出一张布满细胞毒性颗粒的 DNA 网,其作用是固定和杀死入侵的病原体。
NETosis 是一种重要的抗感染途径,过量的 NETosis 已被证明会导致对
我们还表明,来自创伤性损伤小鼠的血清可以启动未激活的中性粒细胞进行 NETosis。
根据这些数据,我们导致创伤导致中性粒细胞出现 NETosis ALI 和过度活跃
为了检验这一假设,我们提出了两个具体目标。
目标 1:确定多发伤诱发的 ALI 引发的中性粒细胞 NETosis 是否会导致肺炎恶化。
目标 2:确定 GCSF 在促进多发伤后 NETosis 中的作用
AIM3:定义中性粒细胞 NETosis 对继发性免疫反应失调的影响
外伤后感染。
成功实现这些目标所获得的知识将为预防和治疗 ALI 提供新的途径。
创伤,并且可以临床转化,因为目前 FDA 批准的几种治疗方法已知具有对抗创伤的活性
目前正在开发 NETosis 所需的关键酶和多种特定疗法。
至关重要,以便伦纳德博士的实验室能够将这些转化为可能改善病情的机械疗法的开发
患者的结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jennifer Leonard其他文献
Jennifer Leonard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jennifer Leonard', 18)}}的其他基金
相似国自然基金
免疫反应基因1(IRG1)在急性肺损伤中的作用及其转录调控机制研究
- 批准号:82300103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TRPV2-AMPK-PKM2信号轴介导的巨噬细胞能量代谢重编程在衰老后肠缺血再灌注所致急性肺损伤中的作用及机制
- 批准号:82372201
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Galectin-1抑制肺泡巨噬细胞线粒体损伤介导的NLRP3活化减轻流感致急性肺损伤的机制研究
- 批准号:82300005
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ANXA3调控肺微血管内皮细胞通透性在脓毒症急性肺损伤中的作用及机制研究
- 批准号:82372180
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PDHA1介导中性粒细胞NETosis在急性肺损伤中的作用及机制研究
- 批准号:82370086
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Development of antibodies to specific cell surface markers to assess macrophage polarization during Adenovirus 14 and 14p1 infection in the Syrian hamster
开发针对特定细胞表面标记物的抗体,以评估叙利亚仓鼠腺病毒 14 和 14p1 感染期间的巨噬细胞极化
- 批准号:
10725702 - 财政年份:2023
- 资助金额:
$ 18万 - 项目类别:
Mechanisms and Therapy of Chronic Graft-vs.-Host Disease
慢性移植物抗宿主病的机制和治疗
- 批准号:
10493794 - 财政年份:2022
- 资助金额:
$ 18万 - 项目类别:
AP-1 as a transcriptional regulator of AT2 cell reversible activation during lung injury response
AP-1 作为肺损伤反应期间 AT2 细胞可逆激活的转录调节因子
- 批准号:
10843725 - 财政年份:2022
- 资助金额:
$ 18万 - 项目类别:
Inflammation and Fibrosis in Pulmonary TB: the INFIN-TB Study
肺结核中的炎症和纤维化:INFIN-TB 研究
- 批准号:
10661832 - 财政年份:2022
- 资助金额:
$ 18万 - 项目类别:
Tuft Cells Modulate Macrophage Response Following Lung Viral Infection
簇细胞调节肺部病毒感染后的巨噬细胞反应
- 批准号:
10453066 - 财政年份:2022
- 资助金额:
$ 18万 - 项目类别: